This inventor holds 1 USPTO granted patent. Top assignee: Immunex Corporation. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Jennifer L. Slack
Introduction
Jennifer L. Slack is a notable inventor based in Poulsbo, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of cytokine-related therapies. Her work has implications for treating various diseases, including certain types of cancer.
Latest Patents
Jennifer L. Slack holds a patent for a cytokine that binds to ST2. This patent includes ST2 ligand polypeptides, DNA sequences, expression vectors, and transformed host cells that are useful in producing ST2 ligand polypeptides. The ST2 ligand polypeptide binds to a receptor expressed on cell types, including certain Hodgkin's Disease-derived tumor cells. This innovation represents a critical advancement in therapeutic options for patients.
Career Highlights
Jennifer is currently associated with Immunex Corporation, where she continues to contribute to groundbreaking research and development in the field of immunology. Her expertise and innovative spirit have positioned her as a valuable asset in her organization.
Collaborations
Throughout her career, Jennifer has collaborated with esteemed colleagues, including Margit Gayle and Hans-Juergen Gruss. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs.
Conclusion
Jennifer L. Slack's contributions to biotechnology and her innovative patent for ST2 ligand polypeptides highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and therapies.